| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.676 | 0.01 | 0.676 | Toll-Like receptor 7 agonist | |||
| 0.671 | 0.01 | 0.671 | Toll-Like receptor agonist | |||
| 0.602 | 0.005 | 0.602 | Calcium channel L-type activator | 0.372 0.101 CID_179887 | ||
| 0.618 | 0.034 | 0.618 | Caspase 9 stimulant | 0.263 0.237 CID_179887 | ||
| 0.508 | 0.009 | 0.508 | Peroxidase inhibitor | 0.285 0.04 CID_179887 | ||
| 0.481 | 0.003 | 0.481 | Ferrochelatase inhibitor | 0.134 0.045 CID_179887 | ||
| 0.502 | 0.032 | 0.502 | 5 Hydroxytryptamine release inhibitor | |||
| 0.491 | 0.034 | 0.491 | Aldehyde oxidase inhibitor | |||
| 0.484 | 0.041 | 0.484 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.317 0.19 CID_179887 | ||
| 0.474 | 0.039 | 0.515 | Histamine release inhibitor | 0.515 0.024 CID_179887 | CID_179887 | |
| 0.48 | 0.047 | 0.603 | Antibacterial | 0.603 0.019 CID_179887 | CID_179887 | |
| 0.436 | 0.005 | 0.436 | Bronchodilator | 0.169 0.025 CID_179887 | ||
| 0.425 | 0.008 | 0.425 | Alpha-N-acetylglucosaminidase inhibitor | 0.151 0.055 CID_179887 | ||
| 0.436 | 0.033 | 0.572 | Spasmolytic | 0.572 0.016 CID_179887 | CID_179887 | |
| 0.399 | 0.056 | 0.399 | Vasodilator, peripheral | |||
| 0.371 | 0.037 | 0.371 | Calcium channel activator | 0.263 0.132 CID_179887 | ||
| 0.414 | 0.083 | 0.414 | Cyclophilin D inhibitor | |||
| 0.381 | 0.054 | 0.486 | Cholesterol antagonist | 0.486 0.035 CID_179887 | CID_179887 | |
| 0.383 | 0.069 | 0.383 | GABA C receptor rho-3 antagonist | |||
| 0.366 | 0.053 | 0.366 | 5 Hydroxytryptamine release stimulant | |||
| 0.347 | 0.038 | 0.347 | Hypoglycemic | |||
| 0.368 | 0.077 | 0.449 | Immunosuppressant | 0.449 0.047 CID_179887 | CID_179887 | |
| 0.32 | 0.036 | 0.32 | 5 Hydroxytryptamine uptake stimulant | 0.193 0.165 CID_179887 | ||
| 0.301 | 0.018 | 0.301 | Neurotrophic factor enhancer | |||
| 0.282 | 0.005 | 0.282 | Photosensitizer | 0.151 0.03 CID_179887 | ||
| 0.273 | 0.004 | 0.273 | MAP3K9 inhibitor | 0.157 0.05 CID_179887 | ||
| 0.297 | 0.034 | 0.297 | Tyrosine 3 hydroxylase inhibitor | 0.183 0.169 CID_179887 | ||
| 0.289 | 0.027 | 0.289 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.302 | 0.041 | 0.302 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.252 | 0.005 | 0.252 | Phenylalanine 4-hydroxylase inhibitor | 0.104 0.024 CID_179887 | ||
| 0.256 | 0.028 | 0.256 | Nitric-oxide synthase stimulant | |||
| 0.267 | 0.04 | 0.267 | Peptidyltransferase inhibitor | |||
| 0.275 | 0.053 | 0.275 | DNA synthesis inhibitor | 0.203 0.118 CID_179887 | ||
| 0.23 | 0.008 | 0.529 | Triose-phosphate isomerase inhibitor | 0.529 0.002 CID_179887 | CID_179887 | |
| 0.242 | 0.025 | 0.242 | Succinate dehydrogenase inhibitor | 0.185 0.063 CID_179887 | ||
| 0.275 | 0.062 | 0.275 | Interleukin agonist | |||
| 0.29 | 0.081 | 0.29 | Interleukin 2 agonist | |||
| 0.224 | 0.02 | 0.224 | Antiadrenergic | |||
| 0.235 | 0.033 | 0.235 | Amylase inhibitor | |||
| 0.22 | 0.02 | 0.22 | Adrenaline antagonist | |||
| 0.211 | 0.014 | 0.211 | Adenylate kinase inhibitor | 0.149 0.027 CID_179887 | ||
| 0.205 | 0.011 | 0.205 | HIV-1 integrase (Overall Integration) inhibitor | 0.139 0.03 CID_179887 | ||
| 0.203 | 0.009 | 0.203 | Sphingomyelinase inhibitor | 0.091 0.071 CID_179887 | ||
| 0.225 | 0.033 | 0.225 | Melanin inhibitor | |||
| 0.285 | 0.093 | 0.285 | Sodium/bile acid cotransporter inhibitor | 0.25 0.128 CID_179887 | ||
| 0.192 | 0.003 | 0.192 | Calcium-sensing receptor antagonist | 0.026 0.007 CID_179887 | ||
| 0.27 | 0.084 | 0.27 | Hypoxia-inducible factor 1 alpha inhibitor | 0.23 0.119 CID_179887 | ||
| 0.192 | 0.018 | 0.192 | Adenylate cyclase stimulant | 0.191 0.018 CID_179887 | ||
| 0.202 | 0.029 | 0.388 | Cell wall synthesis inhibitor | 0.388 0.006 CID_179887 | CID_179887 | |
| 0.251 | 0.08 | 0.251 | DNA damaging | |||
| 0.179 | 0.009 | 0.179 | Somatostatin 1 agonist | 0.088 0.043 CID_179887 | ||
| 0.177 | 0.008 | 0.177 | Ca2+-transporting ATPase inhibitor | 0.142 0.064 CID_179887 | ||
| 0.241 | 0.072 | 0.241 | Hypolipemic | |||
| 0.244 | 0.078 | 0.561 | Superoxide dismutase inhibitor | 0.561 0.009 CID_179887 | CID_179887 | |
| 0.204 | 0.04 | 0.204 | Protein kinase stimulant | |||
| 0.17 | 0.007 | 0.17 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.189 | 0.027 | 0.189 | Cystathionine beta-synthase inhibitor | |||
| 0.23 | 0.069 | 0.23 | Interleukin antagonist | |||
| 0.203 | 0.043 | 0.316 | Diuretic | 0.316 0.02 CID_179887 | CID_179887 | |
| 0.18 | 0.021 | 0.18 | UDP-glucose 4-epimerase inhibitor | |||
| 0.184 | 0.025 | 0.184 | Cyclooxygenase 3 inhibitor | |||
| 0.177 | 0.02 | 0.258 | Catalase inhibitor | 0.258 0.008 CID_179887 | CID_179887 | |
| 0.195 | 0.041 | 0.195 | ATPase inhibitor | |||
| 0.197 | 0.044 | 0.197 | Acetylcholine M1 receptor antagonist | |||
| 0.213 | 0.061 | 0.213 | Insulin sensitizer | |||
| 0.17 | 0.02 | 0.17 | Papain-like protease (SARS coronavirus) inhibitor | 0.115 0.094 CID_179887 | ||
| 0.161 | 0.012 | 0.161 | Adrenaline agonist | |||
| 0.173 | 0.026 | 0.187 | Nav1.4 sodium channel blocker | 0.187 0.022 CID_179887 | CID_179887 | |
| 0.153 | 0.009 | 0.153 | Glutamate release inhibitor | |||
| 0.171 | 0.027 | 0.171 | GABA C receptor agonist | |||
| 0.188 | 0.045 | 0.188 | Arachidonic acid antagonist | 0.139 0.102 CID_179887 | ||
| 0.164 | 0.023 | 0.164 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.201 | 0.06 | 0.201 | 5 Hydroxytryptamine 3E antagonist | 0.17 0.137 CID_179887 | ||
| 0.16 | 0.02 | 0.16 | Creatine kinase inhibitor | 0.112 0.048 CID_179887 | ||
| 0.148 | 0.01 | 0.148 | Alcohol oxidase inhibitor | |||
| 0.154 | 0.019 | 0.154 | Electron transport complex I inhibitor | |||
| 0.258 | 0.126 | 0.258 | Vasodilator, coronary | |||
| 0.15 | 0.018 | 0.16 | Anabolic | 0.16 0.013 CID_179887 | CID_179887 | |
| 0.204 | 0.072 | 0.204 | Anesthetic general | |||
| 0.179 | 0.051 | 0.179 | Interferon gamma antagonist | |||
| 0.166 | 0.038 | 0.166 | Nav1.6 sodium channel blocker | |||
| 0.165 | 0.038 | 0.186 | Cholesterol synthesis inhibitor | 0.186 0.03 CID_179887 | CID_179887 | |
| 0.149 | 0.023 | 0.149 | Calcium antagonist | |||
| 0.171 | 0.046 | 0.171 | Nav1.2 sodium channel blocker | 0.163 0.05 CID_179887 | ||
| 0.137 | 0.016 | 0.137 | Glutamate decarboxylase inhibitor | 0.07 0.055 CID_179887 | ||
| 0.143 | 0.022 | 0.143 | Porphobilinogen synthase inhibitor | 0.076 0.05 CID_179887 | ||
| 0.151 | 0.03 | 0.151 | Carbonic anhydrase XV inhibitor | 0.12 0.046 CID_179887 | ||
| 0.132 | 0.015 | 0.132 | Estrogen receptor alpha antagonist | |||
| 0.133 | 0.023 | 0.133 | NADH dehydrogenase inhibitor | 0.098 0.046 CID_179887 | ||
| 0.242 | 0.132 | 0.428 | Antithrombotic | 0.428 0.043 CID_179887 | CID_179887 | |
| 0.204 | 0.094 | 0.28 | RNA-directed DNA polymerase inhibitor | 0.28 0.036 CID_179887 | CID_179887 | |
| 0.255 | 0.146 | 0.255 | Calpain 2 inhibitor | |||
| 0.122 | 0.015 | 0.122 | Leukotriene antagonist | |||
| 0.149 | 0.043 | 0.149 | DNA intercalator | 0.097 0.076 CID_179887 | ||
| 0.12 | 0.014 | 0.12 | Prostaglandin EP2 antagonist | |||
| 0.116 | 0.01 | 0.116 | Beta 3 adrenoreceptor antagonist | 0.062 0.049 CID_179887 | ||
| 0.162 | 0.059 | 0.162 | GABA C receptor rho-2 antagonist | |||
| 0.152 | 0.05 | 0.152 | Pregnane X receptor agonist | 0.137 0.082 CID_179887 | ||
| 0.133 | 0.034 | 0.133 | Estrogen antagonist | |||
| 0.137 | 0.038 | 0.137 | GABA C receptor antagonist | 0.129 0.044 CID_179887 | ||
| 0.211 | 0.113 | 0.346 | Immunostimulant | 0.346 0.066 CID_179887 | CID_179887 | |
| 0.144 | 0.047 | 0.144 | Acetylcholine muscarinic antagonist | |||
| 0.234 | 0.139 | 0.234 | Transcription factor NF kappa B inhibitor | 0.206 0.163 CID_179887 | ||
| 0.217 | 0.124 | 0.217 | Gastrin inhibitor | |||
| 0.107 | 0.017 | 0.107 | Biliverdin reductase inhibitor | |||
| 0.178 | 0.089 | 0.178 | Non-steroidal antiinflammatory agent | |||
| 0.117 | 0.028 | 0.167 | Cathepsin G inhibitor | 0.167 0.019 CID_179887 | CID_179887 | |
| 0.123 | 0.033 | 0.123 | Alcohol dehydrogenase inhibitor | |||
| 0.157 | 0.068 | 0.158 | Phospholipase A2 inhibitor | 0.158 0.067 CID_179887 | CID_179887 | |
| 0.116 | 0.028 | 0.116 | Ornithine decarboxylase inhibitor | |||
| 0.103 | 0.015 | 0.103 | Beta adrenoreceptor antagonist | |||
| 0.092 | 0.005 | 0.092 | Lysophosphatidic acid 2 receptor antagonist | 0.034 0.017 CID_179887 | ||
| 0.124 | 0.037 | 0.124 | GABA C receptor rho-1 antagonist | |||
| 0.139 | 0.053 | 0.139 | Adenylate cyclase inhibitor | |||
| 0.098 | 0.011 | 0.098 | Glutamate (mGluR6) antagonist | |||
| 0.131 | 0.045 | 0.131 | Mucolytic | |||
| 0.133 | 0.048 | 0.133 | Microtubule formation inhibitor | |||
| 0.1 | 0.015 | 0.1 | Alpha 2 adrenoreceptor agonist | |||
| 0.094 | 0.01 | 0.094 | Aconitate hydratase inhibitor | |||
| 0.124 | 0.04 | 0.124 | DOPA decarboxylase inhibitor | |||
| 0.142 | 0.059 | 0.142 | Toll-Like receptor 2 antagonist | |||
| 0.124 | 0.041 | 0.124 | Urease inhibitor | |||
| 0.142 | 0.06 | 0.142 | NADPH oxidase inhibitor | |||
| 0.094 | 0.012 | 0.094 | Leukotriene B4 antagonist | 0.057 0.032 CID_179887 | ||
| 0.151 | 0.071 | 0.151 | NOS3 expression enhancer | |||
| 0.176 | 0.096 | 0.176 | Psychostimulant | |||
| 0.087 | 0.007 | 0.087 | Lysophosphatidic acid 3 receptor antagonist | 0.063 0.02 CID_179887 | ||
| 0.104 | 0.026 | 0.104 | Aminopeptidase I inhibitor | |||
| 0.127 | 0.049 | 0.21 | Aminopeptidase B inhibitor | 0.21 0.019 CID_179887 | CID_179887 | |
| 0.088 | 0.01 | 0.088 | Potassium channel (Inward rectifier) blocker | |||
| 0.132 | 0.053 | 0.132 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.091 | 0.013 | 0.091 | Beta 1 adrenoreceptor antagonist | |||
| 0.105 | 0.028 | 0.105 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.096 | 0.019 | 0.096 | DNA gyrase inhibitor | |||
| 0.099 | 0.022 | 0.099 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.103 | 0.026 | 0.103 | D-Ala-D-Ala ligase inhibitor | |||
| 0.104 | 0.029 | 0.104 | mTOR complex 2 inhibitor | |||
| 0.131 | 0.057 | 0.131 | Proteasome inhibitor | |||
| 0.093 | 0.02 | 0.093 | Acetylcholine M5 receptor antagonist | |||
| 0.106 | 0.033 | 0.106 | ATPase (Vacuolar H+) inhibitor | |||
| 0.206 | 0.134 | 0.206 | Lipoxygenase inhibitor | |||
| 0.092 | 0.019 | 0.092 | Purinergic P2X1 antagonist | 0.057 0.049 CID_179887 | ||
| 0.082 | 0.011 | 0.082 | Beta 2 adrenoreceptor antagonist | |||
| 0.239 | 0.168 | 0.239 | Antiobesity | |||
| 0.088 | 0.017 | 0.088 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.133 | 0.063 | 0.133 | Cholinergic antagonist | |||
| 0.084 | 0.014 | 0.084 | Glucosylceramidase inhibitor | |||
| 0.133 | 0.063 | 0.177 | Antibacterial (Helicobacter pylori) | 0.177 0.03 CID_179887 | CID_179887 | |
| 0.081 | 0.012 | 0.081 | Potassium channel Kv1.3 blocker | |||
| 0.101 | 0.031 | 0.101 | Phosphofructokinase-1 inhibitor | |||
| 0.1 | 0.032 | 0.119 | Na+ K+ transporting ATPase inhibitor | 0.119 0.017 CID_179887 | CID_179887 | |
| 0.099 | 0.031 | 0.099 | Glutamate dehydrogenase inhibitor | 0.066 0.064 CID_179887 | ||
| 0.13 | 0.061 | 0.13 | DNA polymerase I inhibitor | |||
| 0.129 | 0.06 | 0.144 | Alkylator | 0.144 0.049 CID_179887 | CID_179887 | |
| 0.117 | 0.049 | 0.117 | Beta glucuronidase inhibitor | |||
| 0.076 | 0.009 | 0.076 | Pregnane X receptor antagonist | |||
| 0.081 | 0.014 | 0.081 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.128 | 0.063 | 0.128 | Aldehyde dehydrogenase inhibitor | |||
| 0.085 | 0.02 | 0.085 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.076 | 0.012 | 0.076 | Beta 2 adrenoreceptor agonist | 0.064 0.036 CID_179887 | ||
| 0.141 | 0.078 | 0.141 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.07 | 0.007 | 0.07 | Diamine oxidase inhibitor | |||
| 0.095 | 0.032 | 0.095 | Estrogen-related receptor beta agonist | |||
| 0.127 | 0.065 | 0.127 | Acetylcholine antagonist | |||
| 0.075 | 0.014 | 0.118 | Alpha-mannosidase inhibitor | 0.118 0.005 CID_179887 | CID_179887 | |
| 0.083 | 0.021 | 0.083 | Exportin-1 inhibitor | |||
| 0.115 | 0.053 | 0.115 | Alpha 2c adrenoreceptor antagonist | |||
| 0.111 | 0.051 | 0.114 | Carbonic anhydrase III inhibitor | 0.114 0.049 CID_179887 | CID_179887 | |
| 0.067 | 0.006 | 0.067 | Glucagon receptor antagonist | |||
| 0.103 | 0.043 | 0.134 | Bile acid receptor antagonist | 0.134 0.011 CID_179887 | CID_179887 | |
| 0.086 | 0.026 | 0.086 | Carbamoyl phosphate synthetase inhibitor | 0.054 0.049 CID_179887 | ||
| 0.087 | 0.028 | 0.087 | Secretase beta inhibitor | |||
| 0.094 | 0.034 | 0.094 | Keratolytic | |||
| 0.137 | 0.077 | 0.137 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.063 | 0.005 | 0.063 | Liver X receptor beta antagonist | |||
| 0.069 | 0.012 | 0.069 | Somatostatin 1 antagonist | |||
| 0.107 | 0.051 | 0.107 | Estrogen receptor beta antagonist | |||
| 0.143 | 0.088 | 0.143 | Hexokinase inhibitor | |||
| 0.08 | 0.025 | 0.08 | Argininosuccinate synthase inhibitor | |||
| 0.079 | 0.025 | 0.079 | Androgen agonist | 0.07 0.031 CID_179887 | ||
| 0.058 | 0.004 | 0.074 | Ceramide glucosyltransferase inhibitor | 0.074 0.003 CID_179887 | CID_179887 | |
| 0.066 | 0.013 | 0.114 | Mannosidase inhibitor | 0.114 0.005 CID_179887 | CID_179887 | |
| 0.086 | 0.033 | 0.086 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.074 | 0.022 | 0.074 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.183 | 0.131 | 0.183 | Calpain inhibitor | |||
| 0.174 | 0.122 | 0.174 | Platelet antagonist | |||
| 0.062 | 0.01 | 0.062 | Alpha 1d adrenoreceptor agonist | |||
| 0.085 | 0.033 | 0.085 | GABA B receptor agonist | |||
| 0.056 | 0.004 | 0.056 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.119 | 0.067 | 0.119 | Anesthetic local | |||
| 0.066 | 0.015 | 0.066 | Immunoglobulin Fc receptor antagonist | |||
| 0.07 | 0.02 | 0.158 | Factor IXa inhibitor | 0.158 0.004 CID_179887 | CID_179887 | |
| 0.065 | 0.015 | 0.065 | Glucose-6-phosphate isomerase inhibitor | 0.047 0.034 CID_179887 | ||
| 0.077 | 0.027 | 0.077 | Acetylcholine M3 receptor antagonist | |||
| 0.193 | 0.144 | 0.193 | Transcription factor STAT3 inhibitor | |||
| 0.091 | 0.043 | 0.091 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.083 | 0.036 | 0.083 | Alpha adrenoreceptor agonist | |||
| 0.053 | 0.006 | 0.053 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.062 | 0.014 | 0.062 | Progesterone antagonist | |||
| 0.1 | 0.052 | 0.113 | Phosphodiesterase 6D inhibitor | 0.113 0.033 CID_179887 | CID_179887 | |
| 0.051 | 0.004 | 0.051 | Alpha 2a adrenoreceptor agonist | |||
| 0.11 | 0.063 | 0.11 | Protein kinase C gamma inhibitor | |||
| 0.057 | 0.011 | 0.057 | Somatostatin 5 antagonist | |||
| 0.089 | 0.043 | 0.143 | Glycine receptor antagonist | 0.143 0.009 CID_179887 | CID_179887 | |
| 0.056 | 0.01 | 0.056 | Angiotensin AT1 receptor antagonist | |||
| 0.082 | 0.036 | 0.082 | Glycine receptor agonist | |||
| 0.059 | 0.014 | 0.059 | Retinoid X receptor agonist | |||
| 0.074 | 0.03 | 0.074 | NMDA 2C receptor antagonist | 0.066 0.037 CID_179887 | ||
| 0.15 | 0.106 | 0.265 | Phospholipase C inhibitor | 0.265 0.022 CID_179887 | CID_179887 | |
| 0.106 | 0.062 | 0.106 | Expectorant | |||
| 0.076 | 0.033 | 0.076 | Glutamate (mGluR7) antagonist | |||
| 0.067 | 0.023 | 0.067 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.057 0.033 CID_179887 | ||
| 0.119 | 0.076 | 0.119 | Cathepsin H inhibitor | |||
| 0.047 | 0.004 | 0.047 | Nicotinic acid receptor 2 antagonist | |||
| 0.047 | 0.004 | 0.047 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.115 | 0.072 | 0.115 | Topoisomerase II inhibitor | |||
| 0.094 | 0.052 | 0.094 | Androgen antagonist | |||
| 0.1 | 0.058 | 0.1 | Electrolyte absorption antagonist | |||
| 0.079 | 0.039 | 0.079 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.167 | 0.127 | 0.167 | Free radical scavenger | |||
| 0.117 | 0.077 | 0.117 | Nav1.3 sodium channel blocker | |||
| 0.065 | 0.025 | 0.065 | Thromboxane A2 antagonist | |||
| 0.069 | 0.029 | 0.069 | Calcium channel P-type blocker | |||
| 0.054 | 0.016 | 0.054 | Liver X receptor alpha agonist | |||
| 0.052 | 0.014 | 0.052 | Beta adrenoreceptor agonist | |||
| 0.091 | 0.053 | 0.091 | Bromodomain-containing protein 2 inhibitor | |||
| 0.052 | 0.014 | 0.052 | Membrane dipeptidase inhibitor | |||
| 0.096 | 0.06 | 0.096 | Prolactin inhibitor | |||
| 0.046 | 0.009 | 0.046 | Angiotensin II receptor antagonist | |||
| 0.097 | 0.061 | 0.097 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.103 | 0.067 | 0.103 | Mediator release inhibitor | |||
| 0.055 | 0.019 | 0.055 | Erythropoietin receptor agonist | |||
| 0.062 | 0.026 | 0.062 | Dihydroorotate oxidase inhibitor | |||
| 0.045 | 0.009 | 0.045 | Purinergic P2Y14 antagonist | |||
| 0.12 | 0.085 | 0.12 | Interleukin 4 antagonist | |||
| 0.076 | 0.041 | 0.076 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.076 | 0.041 | 0.126 | Phospholipase D inhibitor | 0.126 0.005 CID_179887 | CID_179887 | |
| 0.063 | 0.03 | 0.063 | Thromboxane antagonist | |||
| 0.067 | 0.034 | 0.067 | Carbonic anhydrase stimulant | |||
| 0.039 | 0.006 | 0.039 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.184 | 0.151 | 0.184 | Neuropeptide Y2 antagonist | |||
| 0.13 | 0.097 | 0.13 | Thiol protease inhibitor | |||
| 0.037 | 0.005 | 0.041 | 1,3-Beta-glucan synthase inhibitor | 0.041 0.004 CID_179887 | CID_179887 | |
| 0.188 | 0.156 | 0.188 | Transcription factor STAT inhibitor | |||
| 0.048 | 0.016 | 0.048 | Heme oxygenase inhibitor | |||
| 0.08 | 0.048 | 0.08 | CYP2A6 inhibitor | |||
| 0.122 | 0.091 | 0.122 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.088 | 0.057 | 0.088 | Histamine N-methyltransferase inhibitor | |||
| 0.099 | 0.068 | 0.099 | Nav1.1 sodium channel blocker | |||
| 0.038 | 0.007 | 0.038 | Sodium/glucose cotransporter inhibitor | |||
| 0.135 | 0.105 | 0.135 | CF transmembrane conductance regulator agonist | |||
| 0.103 | 0.073 | 0.119 | Monophenol monooxygenase inhibitor | 0.119 0.062 CID_179887 | CID_179887 | |
| 0.042 | 0.012 | 0.042 | Cholesterol ester transfer protein antagonist | |||
| 0.068 | 0.038 | 0.068 | Acetylcholine M2 receptor antagonist | |||
| 0.054 | 0.024 | 0.054 | Oleamide hydrolase inhibitor | |||
| 0.102 | 0.073 | 0.102 | Alpha 2b adrenoreceptor antagonist | |||
| 0.042 | 0.013 | 0.042 | Prostaglandin agonist | |||
| 0.056 | 0.027 | 0.056 | Phosphorylase inhibitor | 0.042 0.035 CID_179887 | ||
| 0.048 | 0.02 | 0.048 | Urate transporter 1 inhibitor | |||
| 0.075 | 0.046 | 0.075 | Histidine decarboxylase inhibitor | |||
| 0.04 | 0.011 | 0.04 | Estrogen-related receptor beta antagonist | |||
| 0.038 | 0.01 | 0.038 | Liver X receptor alpha antagonist | |||
| 0.05 | 0.022 | 0.05 | Growth hormone release inhibitor | |||
| 0.058 | 0.03 | 0.058 | Thromboxane synthase inhibitor | |||
| 0.046 | 0.019 | 0.046 | Kainate receptor agonist | |||
| 0.044 | 0.016 | 0.044 | Fumarate hydratase inhibitor | |||
| 0.058 | 0.031 | 0.058 | DNA helicase inhibitor | |||
| 0.193 | 0.167 | 0.193 | Insulysin inhibitor | |||
| 0.031 | 0.005 | 0.031 | Follicle-stimulating hormone antagonist | 0.028 0.005 CID_179887 | ||
| 0.079 | 0.053 | 0.081 | Interferon agonist | 0.081 0.05 CID_179887 | CID_179887 | |
| 0.059 | 0.033 | 0.059 | Sphingosine kinase 2 inhibitor | |||
| 0.039 | 0.013 | 0.039 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.066 | 0.041 | 0.07 | Interferon inducer | 0.07 0.035 CID_179887 | CID_179887 | |
| 0.03 | 0.004 | 0.03 | Alpha 2b adrenoreceptor agonist | |||
| 0.03 | 0.005 | 0.03 | Alpha 2c adrenoreceptor agonist | |||
| 0.042 | 0.017 | 0.042 | Somatostatin 2 antagonist | |||
| 0.045 | 0.02 | 0.045 | GABA uptake inhibitor | |||
| 0.047 | 0.022 | 0.047 | Nerve growth factor antagonist | |||
| 0.051 | 0.027 | 0.051 | Cytokine production stimulant | |||
| 0.035 | 0.011 | 0.035 | Purinergic P2Y15 antagonist | |||
| 0.028 | 0.004 | 0.028 | Tryptophan hydroxylase 1 inhibitor | 0.018 0.009 CID_179887 | ||
| 0.045 | 0.022 | 0.045 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.045 | 0.022 | 0.045 | Dopamine D5 agonist | |||
| 0.039 | 0.016 | 0.039 | Liver X receptor beta agonist | |||
| 0.047 | 0.024 | 0.065 | Guanylate cyclase inhibitor | 0.065 0.007 CID_179887 | CID_179887 | |
| 0.041 | 0.019 | 0.041 | Nicotinic acid receptor agonist | |||
| 0.037 | 0.015 | 0.037 | Liver X receptor antagonist | |||
| 0.054 | 0.033 | 0.104 | Estrogen agonist | 0.104 0.016 CID_179887 | CID_179887 | |
| 0.158 | 0.137 | 0.158 | Antiamyloidogenic | |||
| 0.03 | 0.01 | 0.03 | Prostaglandin E2 agonist | |||
| 0.074 | 0.054 | 0.074 | Vanilloid 4 agonist | |||
| 0.132 | 0.113 | 0.132 | Heat shock protein 70 antagonist | |||
| 0.039 | 0.02 | 0.039 | Retinoid X alpha receptor agonist | |||
| 0.093 | 0.075 | 0.093 | Glutamate (mGluR7) agonist | |||
| 0.023 | 0.005 | 0.023 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.029 | 0.012 | 0.029 | Somatostatin 4 antagonist | |||
| 0.063 | 0.046 | 0.079 | Neuraminidase (influenza) inhibitor | 0.079 0.026 CID_179887 | CID_179887 | |
| 0.032 | 0.016 | 0.032 | DNA topoisomerase IV inhibitor | |||
| 0.025 | 0.01 | 0.025 | Imidazoline I1 receptor antagonist | |||
| 0.026 | 0.011 | 0.026 | Integrin alpha4beta7 antagonist | |||
| 0.028 | 0.013 | 0.028 | Prostaglandin EP2 agonist | |||
| 0.05 | 0.035 | 0.05 | Factor III inhibitor | |||
| 0.022 | 0.007 | 0.022 | Antibiotic Anthracycline-like | |||
| 0.033 | 0.018 | 0.033 | Prostaglandin D2 agonist | |||
| 0.059 | 0.044 | 0.059 | Neuraminidase inhibitor | 0.058 0.046 CID_179887 | ||
| 0.045 | 0.03 | 0.045 | Dihydroorotase inhibitor | |||
| 0.025 | 0.012 | 0.025 | Beta 1 adrenoreceptor agonist | |||
| 0.035 | 0.022 | 0.035 | Free fatty acid receptor 1 antagonist | |||
| 0.038 | 0.026 | 0.038 | Glutamate (mGluR8) agonist | |||
| 0.023 | 0.011 | 0.023 | Neuraminidase (Influenza B) inhibitor | |||
| 0.028 | 0.017 | 0.028 | Hedgehog signaling activator | |||
| 0.045 | 0.034 | 0.045 | Adenylate cyclase 1 inhibitor | |||
| 0.024 | 0.013 | 0.024 | Leukotriene B4 receptor 2 antagonist | |||
| 0.045 | 0.035 | 0.045 | Thymidylate synthase inhibitor | |||
| 0.104 | 0.095 | 0.104 | Transcription factor STAT6 inhibitor | |||
| 0.048 | 0.039 | 0.048 | Squalene epoxidase inhibitor | |||
| 0.028 | 0.019 | 0.028 | Leukotriene B4 receptor 1 antagonist | |||
| 0.027 | 0.018 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.049 | 0.04 | 0.049 | Ornithine carbamoyltransferase inhibitor | |||
| 0.048 | 0.04 | 0.048 | CD45 antagonist | |||
| 0.046 | 0.037 | 0.046 | Benzodiazepine antagonist | |||
| 0.045 | 0.037 | 0.045 | CC chemokine 4 receptor antagonist | |||
| 0.054 | 0.047 | 0.054 | Leukotriene C antagonist | |||
| 0.06 | 0.053 | 0.06 | Aryl hydrocarbon receptor antagonist | |||
| 0.031 | 0.023 | 0.031 | ATP citrate lysase inhibitor | |||
| 0.039 | 0.032 | 0.039 | Thymidine kinase inhibitor | |||
| 0.021 | 0.014 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.022 | 0.016 | 0.022 | Prostaglandin F2 alpha agonist | |||
| 0.03 | 0.023 | 0.03 | Cyclophilin A inhibitor | |||
| 0.139 | 0.132 | 0.139 | Neurotensin receptor agonist | |||
| 0.122 | 0.116 | 0.122 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.062 | 0.056 | 0.062 | Potassium channel (ATP-sensitive) blocker | |||
| 0.035 | 0.03 | 0.035 | TRPM8 blocker | |||
| 0.031 | 0.026 | 0.031 | Estrogen receptor alpha agonist | |||
| 0.055 | 0.05 | 0.055 | Sphingosine kinase inhibitor | |||
| 0.041 | 0.036 | 0.041 | Geranyltranstransferase inhibitor | |||
| 0.033 | 0.027 | 0.059 | Phosphoglycerate kinase inhibitor | 0.059 0.011 CID_179887 | CID_179887 | |
| 0.02 | 0.015 | 0.02 | Retinoid X beta receptor antagonist | |||
| 0.042 | 0.038 | 0.053 | Adenosine deaminase inhibitor | 0.053 0.027 CID_179887 | CID_179887 | |
| 0.015 | 0.01 | 0.015 | Prostaglandin EP4 agonist | |||
| 0.012 | 0.008 | 0.012 | Immunosuppressant Cyclosporine-like | |||
| 0.042 | 0.038 | 0.042 | Glycine transporter inhibitor | |||
| 0.036 | 0.033 | 0.036 | Vanilloid 3 antagonist | |||
| 0.035 | 0.032 | 0.035 | Retinoid X receptor antagonist | |||
| 0.016 | 0.013 | 0.016 | Telomerase stimulant | |||
| 0.016 | 0.013 | 0.016 | Vitamin D receptor agonist | |||
| 0.027 | 0.024 | 0.027 | Estrogen-related receptor gamma antagonist | |||
| 0.079 | 0.076 | 0.079 | Interleukin 5 antagonist | |||
| 0.031 | 0.029 | 0.031 | Retinoid X alpha receptor antagonist | |||
| 0.024 | 0.022 | 0.024 | Kynurenine 3 monooxygenase inhibitor | 0.023 0.022 CID_179887 | ||
| 0.013 | 0.011 | 0.013 | Angiotensin AT1B receptor antagonist | |||
| 0.068 | 0.066 | 0.068 | GABA aminotransferase inhibitor | |||
| 0.081 | 0.08 | 0.081 | 5-Lipoxygenase inhibitor | |||
| 0.02 | 0.019 | 0.02 | Follicle-stimulating hormone agonist | |||
| 0.058 | 0.057 | 0.058 | Leukotriene synthesis inhibitor | |||
| 0.023 | 0.022 | 0.023 | Vanilloid 2 agonist | |||
| 0.096 | 0.096 | 0.102 | TRPA1 agonist | 0.102 0.084 CID_179887 | CID_179887 | |
| 0.074 | 0.074 | 0.092 | NMDA receptor antagonist | 0.092 0.052 CID_179887 | CID_179887 | |
| 0.156 | 0.159 | 0.165 | Antioxidant | 0.165 0.147 CID_179887 | CID_179887 | |
| 0.069 | 0.074 | 0.077 | Carbonic anhydrase VI inhibitor | 0.077 0.06 CID_179887 | CID_179887 | |
| 0.021 | 0.033 | 0.117 | NMDA 2D receptor antagonist | 0.117 0.004 CID_179887 | CID_179887 | |
| 0.051 | 0.065 | 0.104 | NMDA receptor agonist | 0.104 0.018 CID_179887 | CID_179887 | |
| 0.015 | 0.034 | 0.092 | Glutamate (mGluR1a) agonist | 0.092 0.004 CID_179887 | CID_179887 | |
| 0.057 | 0.077 | 0.112 | HIV-1 integrase inhibitor | 0.112 0.019 CID_179887 | CID_179887 | |
| 0.056 | 0.076 | 0.118 | Carbonic anhydrase XIII inhibitor | 0.118 0.03 CID_179887 | CID_179887 | |
| 0.09 | 0.114 | 0.126 | Acetylcholine release stimulant | 0.126 0.04 CID_179887 | CID_179887 | |
| 0.024 | 0.049 | 0.051 | Farnesoid X receptor agonist | 0.051 0.014 CID_179887 | CID_179887 | |
| 0.035 | 0.062 | 0.117 | Carbonic anhydrase VB inhibitor | 0.117 0.013 CID_179887 | CID_179887 | |
| 0.013 | 0.04 | 0.028 | Estrogen receptor beta agonist | 0.028 0.024 CID_179887 | CID_179887 | |
| 0.042 | 0.07 | 0.077 | Heparanase inhibitor | 0.077 0.008 CID_179887 | CID_179887 | |
| 0.046 | 0.082 | 0.086 | NMDA 2 receptor antagonist | 0.086 0.039 CID_179887 | CID_179887 | |
| 0.048 | 0.087 | 0.058 | Protease 3C (Human rhinovirus) inhibitor | 0.058 0.057 CID_179887 | CID_179887 | |
| 0.041 | 0.088 | 0.124 | Carbonic anhydrase V inhibitor | 0.124 0.02 CID_179887 | CID_179887 | |
| 0.044 | 0.094 | 0.084 | Carbonic anhydrase VA inhibitor | 0.084 0.034 CID_179887 | CID_179887 | |
| 0.016 | 0.066 | 0.035 | Glutamate (mGluR1) agonist | 0.035 0.007 CID_179887 | CID_179887 | |
| 0.054 | 0.129 | 0.075 | Inducible nitric-oxide synthase inhibitor | 0.075 0.072 CID_179887 | CID_179887 | |
| 0.047 | 0.126 | 0.311 | CDC25A inhibitor | 0.311 0.004 CID_179887 | CID_179887 | |
| 0.064 | 0.146 | 0.104 | Protein kinase C zeta inhibitor | 0.104 0.045 CID_179887 | CID_179887 | |
| 0.096 | 0.184 | 0.27 | Hemostatic | 0.27 0.019 CID_179887 | CID_179887 | |
| 0.021 | 0.113 | 0.068 | Leukocyte elastase inhibitor | 0.068 0.015 CID_179887 | CID_179887 | |
| 0.039 | 0.139 | 0.074 | Adenine nucleotide translocase inhibitor | 0.074 0.012 CID_179887 | CID_179887 | |
| 0.025 | 0.134 | 0.267 | Selectin antagonist | 0.267 0.007 CID_179887 | CID_179887 | |
| 0.018 | 0.141 | 0.549 | Cholecystokinin B agonist | 0.549 0.002 CID_179887 | CID_179887 | |
| 0.004 | 0.159 | 0.064 | Estrone sulfatase inhibitor | 0.064 0.006 CID_179887 | CID_179887 | |
| 0.018 | 0.182 | 0.111 | HIV-1 integrase (Strand Transfer) inhibitor | 0.111 0.019 CID_179887 | CID_179887 | |
| 0.039 | 0.223 | 0.075 | Chymotrypsin inhibitor | 0.075 0.061 CID_179887 | CID_179887 | |
| 0.018 | 0.22 | 0.106 | HIV-1 integrase (3'-Processing) inhibitor | 0.106 0.024 CID_179887 | CID_179887 | |
| 0.005 | 0.216 | 0.106 | Cholecystokinin antagonist | 0.106 0.008 CID_179887 | CID_179887 | |
| 0.043 | 0.262 | 0.122 | Alkaline phosphatase inhibitor | 0.122 0.084 CID_179887 | CID_179887 | |
| 0.026 | 0.251 | 0.161 | Protein-tyrosine phosphatase 1B inhibitor | 0.161 0.041 CID_179887 | CID_179887 | |
| 0.106 | 0.344 | 0.304 | 15-Lipoxygenase inhibitor | 0.304 0.13 CID_179887 | CID_179887 | |
| 0.013 | 0.254 | 0.053 | Purinergic P2Y2 antagonist | 0.053 0.009 CID_179887 | CID_179887 | |
| 0.004 | 0.256 | 0.08 | Cholecystokinin B antagonist | 0.08 0.005 CID_179887 | CID_179887 | |
| 0.153 | 0.41 | 0.399 | Antiinflammatory | 0.399 0.14 CID_179887 | CID_179887 | |
| 0.014 | 0.274 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.011 CID_179887 | CID_179887 | |
| 0.043 | 0.333 | 0.422 | Angiogenesis stimulant | 0.422 0.018 CID_179887 | CID_179887 | |
| 0.012 | 0.316 | 0.222 | NMDA 2B receptor antagonist | 0.222 0.005 CID_179887 | CID_179887 | |
| 0.033 | 0.337 | 0.346 | Protein-tyrosine phosphatase inhibitor | 0.346 0.013 CID_179887 | CID_179887 | |
| 0.039 | 0.375 | 0.611 | Dual specificity phosphatase inhibitor | 0.611 0.004 CID_179887 | CID_179887 | |
| 0.004 | 0.369 | 0.274 | Cholecystokinin A agonist | 0.274 0.002 CID_179887 | CID_179887 | |
| 0.004 | 0.375 | 0.352 | Cholecystokinin agonist | 0.352 0.002 CID_179887 | CID_179887 | |
| 0.023 | 0.454 | 0.369 | Thrombolytic | 0.369 0.014 CID_179887 | CID_179887 | |
| 0.037 | 0.48 | 0.135 | Platelet adhesion inhibitor | 0.135 0.124 CID_179887 | CID_179887 | |
| 0.004 | 0.448 | 0.154 | Cholecystokinin A antagonist | 0.154 0.005 CID_179887 | CID_179887 | |
| 0.009 | 0.456 | 0.058 | Elastase inhibitor | 0.058 0.032 CID_179887 | CID_179887 | |
| 0.058 | 0.536 | 0.253 | Immunomodulator | 0.253 0.113 CID_179887 | CID_179887 | |
| 0.044 | 0.525 | 0.469 | Angiogenesis inhibitor | 0.469 0.036 CID_179887 | CID_179887 | |
| 0.02 | 0.538 | 0.573 | Anticoagulant | 0.573 0.007 CID_179887 | CID_179887 | |
| 0.018 | 0.558 | 0.602 | Dual specificity phosphatase 3 inhibitor | 0.602 0.004 CID_179887 | CID_179887 | |
| 0.014 | 0.661 | 0.112 | Viral attachment inhibitor | 0.112 0.017 CID_179887 | CID_179887 | |
| 0.005 | 0.749 | 0.067 | Thrombin inhibitor | 0.067 0.059 CID_179887 | CID_179887 | |
| 0.009 | 0.813 | 0.112 | Multidrug resistance-associated protein 1 inhibitor | 0.112 0.059 CID_179887 | CID_179887 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |